News

Tue Jan 18, 2011

Zev Gartner, PhD, a faculty member in the UCSF School of Pharmacy, will lead a US$3.2 million grant to study the interaction of different types of cells in breast cancer at its earliest stages. Research results might ultimately identify new classes of targets for anticancer drugs. The project is funded by the U.S. Department of...

Tue Jan 11, 2011

A box just four-feet square is the latest addition to the analytical armory of the National Bio-Organic Biomedical Mass Spectrometry Resource Center, which is directed by Al Burlingame, PhD, a faculty member in the Department of Pharmaceutical Chemistry at the UCSF School of Pharmacy.

The diminutive US$1 million mass...

Wed Dec 22, 2010
Table of contents Introduction Budget significance Reasons for past success A decade of funding for bioinformatics New drug discovery directions attract support Research stalwarts draw funding for decades New directions in translational research attract support Expansion of the School’s research agenda brings support New roads to...
Mon Dec 13, 2010

The national winners of the 2010 American Society of Health-System Pharmacists (ASHP) Clinical Skills Competition are Jennifer Murphy and Rachelle Bermingham, student pharmacists from the UCSF School of Pharmacy.

The ASHP competition involves both a written and oral evaluation of a...

Fri Dec 10, 2010

Logic gates, similar to those that form the basis of silicon computing, can now be inserted into bacteria via genetic engineering, making it possible to manipulate bacteria to perform complicated tasks. This finding will ultimately enable cells to be programmed with more intricate functions, allowing cells to produce pharmaceuticals, materials...

Fri Dec 10, 2010

The implantable bioartificial kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.

Learn how the implantable bioartificial kidney works See an animation of the device in action View Shuvo Roy at work in...
Thu Nov 18, 2010

Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartificial kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years. The bioartificial kidney both filters toxins from the blood and...

Thu Nov 18, 2010

Nancy Nkansah, PharmD, a faculty member in the UCSF School of Pharmacy, appears with Mehmet Oz, MD, on The Dr. Oz Show to correct 3 common medication mistakes made by consumers:

The belief that all over-the counter (OTC) drugs are safe. Their advice? Read the label. Many...
Mon Nov 15, 2010

California Poison Control System (CPCS) pharmacist and toxicologist Kathryn Meier, PharmD, DABAT, cites hypertension, tachycardia, anxiety as among the symptoms seen in emergency room patients who have used synthetic cannabinoids. These products have sickened more than 1,500 people across the United States in 2010 and are...